$6.91
-0.65%Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables. The Communications Systems segment provides communications systems and accessories to support military communications systems, such as radio frequency amplifiers, power supplies and cables, connector assemblies, amplified speakers, equipment mounts, case equipment, man-portable systems, and integrated communication systems for fixed or vehicle applications comprising vehicle adapters, vehicle installed power enhanced rifleman appliquรฉ systems, and SATCOM systems. This segment's military communications systems and accessories are designed to enhance and extend the operation of communications equipment, such as vehicle-mounted, manpack, and handheld transceivers. It sells its products under the Ultralife, Ultralife Thin Cell, Utralife HiRate, Ultralife and design, Ultra, Lithium Power, LithiumPower and Design, McDowell Research, AMTI, ABLE, ACCUTRONICS, ACCUPRO, ENTELLION, SWE Southwest Electronic Energy Group, SWE DRILL-DATA, and SWE SEASAFE brands through original equipment manufacturers, and industrial and defense supply distributors, as well as directly to the United States and international defense departments. In addition, the company sells its 9-volt battery to the broader consumer market through national and regional retail chains and online retailers. Ultralife Corporation serves government, defense, and commercial sectors. The company was incorporated in 1990 and is headquartered in Newark, New York.
Negative free cash flow despite positive earnings raises concerns about cash generation ability or heavy capital requirements.
Moderate capital requirements typical of many stable businesses. Healthy balance between reinvestment and cash generation.
Significant FCF decline raises concerns. Urgent review needed of operational performance and capital allocation.
Working capital inflow boosted cash flow. Efficient management of receivables, inventory, and payables contributing positively.
Deteriorating cash generation: Both declining FCF and weak conversion rate signal fundamental challenges. Investigate margin pressure, rising costs, or working capital issues.
ULBI โข NASDAQ
| Ultralife Corporation Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | Dec 2007 | Dec 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | ||||||||||||||||||||
-5.9M | 6.4M | 7.2M | -120K | -230K | 5.3M | 5.3M | 25M | 7.7M | 3.5M | 2.8M | -2.1M | -1.1M | -1.1M | 1.6M | -6.2M | -9.2M | 13.7M | 5.6M | -27.5M | |
5.5M | 4.2M | 3.9M | 4.5M | 3.5M | 2.9M | 2.7M | 2.4M | 2.4M | 2.7M | 235K | 305K | 402K | 497K | 4.3M | 5.4M | 5.7M | 6M | 6.2M | 4.9M | |
-2.5M | 1.2M | 1.3M | -962K | -147K | 1.4M | 1.2M | -18.6M | -1.7M | 135K | 183K | 196K | 113K | 15K | 496K | -115K | 360K | 3.3M | 77K | 23.7M | |
935K | 698K | 528K | 776K | 671K | 943K | 753K | 890K | 653K | 710K | 571K | 1M | 1.1M | 1.4M | 1.2M | 1.1M | 1.3M | 2.3M | 2.1M | 1.5M | |
12.4M | 253K | 33K | 36K | 104K | -1.5M | 44K | 36K | 47K | 76K | 2.7M | 3.2M | 2.2M | 3.2M | 2.2M | 13.8M | 740K | 4.4M | -6.3M | 321K | |
(0.0) | (722K) | (769K) | (354K) | (324K) | (264K) | (266K) | (220K) | (345K) | (273K) | (52K) | (60K) | (100K) | (237K) | (353K) | (1K) | (605K) | (0.0) | (0.0) | (0.0) | |
602K | 3.9M | -11M | -5.5M | 388K | 12.7M | -13M | 1.2M | -1.9M | 524K | 2M | 1.1M | 4.2M | 823K | 1.2M | -3M | 3.1M | -10.5M | -6.1M | -2.8M | |
11M | 16.6M | 1.9M | -1.3M | 4.3M | 21.7M | -3M | 10.9M | 7.3M | 7.7M | 8.6M | 3.7M | 6.9M | 4.8M | 11M | 10.9M | 2M | 19.1M | 1.6M | 151K | |
INVESTING ACTIVITIES | ||||||||||||||||||||
-3.9M | -1.9M | -2.6M | -1.7M | -2.8M | -3.1M | -6.3M | -4.2M | -1.4M | -1.2M | -2.9M | -1.7M | -766K | -2.7M | -2.4M | -1.8M | -2M | -3.8M | -2.1M | -1.5M | |
(0.0) | -48M | (0.0) | (0.0) | -23.5M | (120K) | -25.2M | (0.0) | (0.0) | -9.9M | (0.0) | (0.0) | (0.0) | (0.0) | -50K | -137K | -6.8M | -3.2M | -8.7M | -7M | |
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 65K | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -4.2M | 0.0 | 65K | -2.9M | 268K | 497K | 1.9M | 413K | 1K | -6.8M | -3.2M | -8.7M | -7M | |
-3.9M | -50M | -2.6M | -1.7M | -26.3M | -3M | -31.5M | -4.2M | -1.4M | -11M | -2.9M | -1.4M | -269K | -812K | -2M | -2M | -8.8M | -7M | -10.8M | -8.5M | |
FINANCING ACTIVITIES | ||||||||||||||||||||
98K | 2M | -8K | -15K | -148K | 238K | -2M | -742K | 0.0 | -607K | -9.4M | -762K | 0.0 | 115K | 73K | 55K | -3M | 711K | 13.9M | 1.2M | |
-4.8M | 29.3M | 4.3M | 517K | 19.5M | -15.8M | 17.3M | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -8.5M | -10.5M | 13.7M | -13.4M | -3.5M | 4.4M | |
(0.0) | (0.0) | -8K | -15K | -148K | (0.0) | -2M | -742K | -26K | -607K | -9.4M | -762K | (0.0) | (0.0) | (0.0) | (0.0) | -3.3M | -1.8M | (0.0) | (0.0) | |
-24K | -1.4M | 1.2M | -115K | -262K | -90K | 765K | 2M | 1.4M | 460K | -18K | 11K | 12K | 0.0 | -128K | -151K | 6K | 0.0 | 0.0 | 0.0 | |
-4.7M | 29.9M | 5.5M | 518K | 19.6M | -15.7M | 16.1M | 1.2M | 1.4M | -175K | -8.9M | -751K | 12K | 115K | -8.6M | -10.6M | 10.8M | -12.7M | 10.4M | 5.7M | |
CASH FLOW SUMMARY | ||||||||||||||||||||
49K | 34K | -302K | -276K | 126K | 203K | -154K | -265K | 331K | -231K | -91K | 116K | -230K | 265K | 320K | 218K | 224K | 256K | 280K | 163K | |
2.5M | -3.4M | 4.6M | -2.7M | -2.2M | 3.2M | -18.5M | 7.6M | 7.6M | -3.8M | -3.3M | 1.6M | 6.4M | 4.3M | 679K | -1.5M | 4.2M | -367K | 1.5M | -2.5M | |
6.9M | 10.3M | 5.7M | 8.4M | 10.7M | 7.4M | 25.9M | 18.3M | 10.6M | 14.4M | 17.7M | 16.1M | 9.7M | 5.3M | 4.6M | 6.1M | 1.9M | 2.2M | 720K | 3.2M | |
9.3M | 6.9M | 10.3M | 5.7M | 8.4M | 10.7M | 7.4M | 25.9M | 18.2M | 10.6M | 14.4M | 17.7M | 16.1M | 9.7M | 5.3M | 4.6M | 6.1M | 1.9M | 2.2M | 720K | |
7.1M | 14.7M | -623K | -2.9M | 1.5M | 18.6M | -9.3M | 6.7M | 5.9M | 6.4M | 5.6M | 2M | 6.1M | 2.1M | 8.6M | 9.1M | -3K | 15.3M | -504K | -1.3M |
ULBI - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | June 02, 2026 | July 22, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 08, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 08, 2026 | May 08, 2026 | 2026 | |
10-K/A 10-K/A 2025 FY (Amended) FY | April 29, 2026 | December 31, 2025 | 2025 | |
10-K 10-K 2025 FY FY | March 23, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | March 10, 2026 | March 10, 2026 | 2026 | |
8-K 8-K 2025 N/A | November 18, 2025 | November 18, 2025 | 2025 | |
10-Q 10-Q 2025 Q3 Q3 | November 17, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | August 27, 2025 | August 22, 2025 | 2025 | |
10-Q 10-Q 2025 Q2 Q2 | August 07, 2025 | June 30, 2025 | 2025 |
Continue your ULBI research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.